INTRODUCTION
Traditional drug delivery systems, typically tablets or intravenous injections, administer the entire dose of drug in one part of the body resulting in high, sometimes close to toxic, plasma concentrations of drug, frequently leading to adverse reactions (Pathak et al 2010) . Short duration times require repetitive administration, which is inconvenient for the patient and lead to strongly fluctuating drug levels in the body. Moreover, conventional delivery is unpredictable and inefficient; often a high dose of drug is needed to ensure that the required amount of agent eventually reaches the site of action. The therapeutic effect is achieved, however, not simply by administration of the drug but rather by attaining a long-term appropriate drug concentration.
Sustained drug delivery technology represents one of the frontier areas of science, which involves a multidisciplinary scientific approach, contributing to human health care. These delivery systems offer numerous advantages compared to conventional dosage forms, which include improved efficacy, reduced toxicity and improved patient compliance and convenience.
It involves releasing the drug into the blood stream at predetermined rates over a period of time. Sustained drug delivery is a broad field, involving pharmaceutical, chemical engineering, biological, biomaterials and medical sciences. Its primary goal is to provide effective therapy for a long period of time while reducing or eliminating many of the side effects associated with conventional drug therapy (Szycher 1986) . The sustained drug delivery system is therefore characterized by releasing the drug in a controlled fashion to maintain an appropriate, therapeutic plasma concentration for a long period of time, and by providing the drug only where and when it is needed. The traditional and sustained drug delivery systems are schematically compared in (1) they can pass through the smallest capillary vessels because of their extremely small volume and avoid rapid clearance by phagocytes so that their duration in blood stream is greatly prolonged; (2) they can penetrate cells and tissue gaps to arrive at target organs such as the liver, spleen, lung, spinal cord and lymph nodes; (3) they could show controlled-release properties due to the biodegradability, pH, ion and/or temperature sensibility of materials and (4) they can improve the effectiveness of drugs and reduce toxic side effects. As a drug delivery system, nanoparticles can entrap drugs or biomolecules into their interior structures and/or absorb drugs or biomolecules onto their exterior surfaces. Presently, nanoparticles have been widely used to deliver drugs, polypeptides, proteins, vaccines, nucleic acids, genes and so on. Over the years, nanoparticle drug delivery systems have shown huge potential in biological, medical and pharmaceutical applications (Liu et al 2008) .
Ceramics can be described as "solid compounds that are comprising at least one metal and a non-metallic elemental solid or a nonmetal, a combination of at least two non-metallic elemental solids, or a combination of at least two non-metallic elemental solids and a non-metal".
Ceramics comprised of calcium phosphates, silica, alumina, zirconia and titanium dioxide are nowadays used for various medical applications due to their positive interactions with human tissues. The poor degradability of the ceramic materials lead to the addition of biodegradable polymers to improve both the degradability and also the drug release profile (Habraken et al 2007) .
The use of bioceramics loaded with antibiotic has proven to be extremely effective (Gautier et al 2000) . Biopolymer and inorganic material have a strong interfacial interaction between them by the electrostatic interaction and hydrogen bonding. The mechanical properties, swelling behaviour, drug loading efficiency and controlled release behaviour are enhanced because of this synergistic effect (Zhang et al 2010) .
Alginate (alg) is used in the present study as a polymeric vehicle for sustained drug delivery. Alginate was chosen due to its biocompatibility, non-toxic nature, good shelf life and versatility. The structure of sodium alginate is shown in Figure 4 .2. Alginate is an anionic polysaccharide of (1- 
Drug Release-In Vitro Study
In order to determine the drug release profile, 100 mg of the drug loaded HAp and drug loaded HAp with alginate coating were introduced into a screw capped glass bottle containing 50 ml of phosphate buffered saline (PBS) medium at 37°C and pH 7.4 under sterile conditions. The drug release study was done for a period of 30 hours. 5 ml samples were withdrawn by a pipette and replaced immediately with 5 ml of fresh PBS medium, which was accounted for when calculating the amount released. CPX concentration in the collected samples was measured spectrophotometrically at a wavelength of 274 nm. Mean, standard deviation and one way analysis of variance (ANOVA) was carried out. The wavelength of light absorbed is characteristic of the chemical bond as can be seen in the annotated spectrum. By interpreting the infrared absorption spectrum, the chemical bonds in a molecule can be determined. FTIR spectra of pure compounds are generally so unique that they are like a molecular "fingerprint". For most common materials, the spectrum of an unknown can be identified by comparison to a library of known compounds. To identify less common materials, IR spectra need to be combined with nuclear magnetic resonance, mass spectrometry, emission spectroscopy, X-ray diffraction, and other techniques.
Molecular bonds vibrate at various frequencies depending on the elements and the type of bonds. The frequencies correspond to the ground state (lowest frequency) and several excited states (higher frequencies). One way to cause the frequency of a molecular vibration to increase is to excite the bond by having it absorb light energy. For any given transition between two states the light energy (determined by the wavelength) must be exactly equal to the difference in the energy between the two states [usually ground state (E 0 ) and the first excited state (E 1 )]. Difference in the energy state = energy
where h is the Planck's constant, c is the velocity of the light, λ is the wavelength of the light.
A Perkin Elmer-Spectrum One spectrometer was used for the FT-IR analysis. The spectra were recorded over the range 400 -4000 cm -1 with a resolution of 4 cm -1 .
The FTIR spectrum of HAp nanoparticles is shown in Figure 4 .4.
In the free state the phosphate ion has T d symmetry with its vibrational modes distributed as Γ = A 1 + E +2F 2 , where the A1 (υ1) and E (υβ) species are Raman active only while the two F 2 (υγ and υ4) species are both IR and At a ratio of 2:1, the maximum amount of the drug is loaded per mg of HAp.
When the amount of drug is increased, there is no further increase in the amount of the drug loaded per mg of HAp. 0.8 mg of ciprofloxacin is the maximum of the drug loaded per mg of HAp nanoparticles. Figure 4 .8. The percentage of drug released in 30 hours from CPX coated HAp was found to be 100 %, and from the alginate incorporated sample was found to be only as 80%. The drug is released gradually over a period of time. This shows that the drug is released in a sustained manner. The amount of drug released in 1 hour is well above the minimum inhibition concentration of CPX which is 0.25-β g/ml for pathogens like S. aureus and P. aeruginosa which cause bone infections.
In 1 hour 36% of the drug is released from the CPX coated HAp but it is For the drug release from the composite in the initial stage of the HAp setting process, free ions are released from HAp and pH increases from 7.25 to 8.0. In the initial stages, the release rate from composite is high for some time, and then it declines and remains constant for an extended period.
This initial burst of drug may be due to the shrinkage of HAp volume. The release rate depends on the diffusion of the drug in the pores. Diffusivity of drug is indirectly proportional to its molecular weight. The release rate from the composite increased with decreasing diameter of HAp, reflecting the surface area of HAp. The drug release was highly affected by the diffusion process, along with the coating degradation. The drug release was dominated not only by the diffusion of the drug through the coating layer, but also by the dissolution of the alginate. The drug itself is hydrophilic; it absorbs water easily, facilitating the diffusion through the coating layer.
CONCLUSIONS
HAp alginate nanocomposites to be used as a sustained drug delivery system were synthesized and characterized. Alginate did not induce any modification in the structure of the ceramic. CPX was loaded on HAp nanoparticles before alginate encapsulation. Drug absorption and drug release studies were performed. There is an initial burst in the release of CPX. The amount of drug released in 1 hour is well above the minimum inhibition concentration of CPX, but the alginate encapsulation prolongs the drug release.
